Skip to content

SCHEDULE 13GAccepted Feb 14, 4:29 PM ET

Quince Therapeutics, Inc. SCHEDULE 13G

Sofinnova Partners SAS

sec.gov(opens the filing on sec.gov)

Accepted (ET)

4:29 PM

Feb 14, 2025

Filed

Feb 14, 2025

Documents

2

Size

29.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.